ubs vitainvest - finlantern · pdf fileubs vitainvest world 25 ubs vitainvest world 75 ubs...
Post on 07-Feb-2018
263 Views
Preview:
TRANSCRIPT
For qualified investors only
November 2015
UBS Vitainvest
Expanding Vitainvest - Fundsfamily: UBS Vitainvest 75
1
Table of contents
Section 1 Offering of UBS Vitainvest Funds 2
Section 2 Investment process 7
Appendix A Technical data 13
Offering of UBS Vitainvest Funds
Section 1
3
Global or Swiss focus
Data as end of August 2015. Above allocation shows long term orientation and can be subject to changes at UBS discretion.
For investors with a global focus, to benefit from opportunities in a very broad investment universe
For investors with a Swiss focus, to benefit from an investment universe they are more familiar with
UBS Vitainvest World UBS Vitainvest Swiss
UBS (CH) Vitainvest – 25 World UBS (CH) Vitainvest – 25 Swiss
Swiss Bonds (incl. SBI For) Swiss Equity
Swiss Real Estate Global Bonds Global Equity
Global Real Estate
4
Lower interest rates = Lower long-term returns
We live in a lower return world
¹Source: UBS AM, Valmod, Thomson Reuters DataStream. ²Source: UBS AM; Note: Only for illustration
Capital Markets Line²
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
10%
0% 5% 10% 15% 20% 25% 30%
Exp
ect
ed
re
turn
s
Expected risk US Equity (Large Caps)
EM Equity (Asia)
Eurozone Equity
US Corporate Bonds
US High Yield
EMD (Asia)
US Real Estate
US Govt Bonds
0
1
2
3
4
5
6
7
8BARCLAYS US TREASURY BWTS 30 YEARS - RED. YIELD
US FEDERAL FUNDS TARGET RATE - MIDDLE RATE
US Treasury Yields, Fed Funds Rate¹
%
5
Safe or with more risk?
For more cautious investors who prefer fixed income exposure with a given yield
For investors who are able to take more risk to increase the return potential
UBS Vitainvest World 25 UBS Vitainvest World 75
UBS (CH) Vitainvest – 25 World UBS (CH) Vitainvest – 75 World
Swiss Bonds (incl. SBI For) Swiss Equity
Swiss Real Estate Global Bonds Global Equity
Global Real Estate
Data as end of August 2015. Above allocation shows long term allocation and can be subject to changes at UBS discretion.
6
Performance Vitainvest Data as end of October, 2015
80
90
100
110
120
130
140
Oct-10 Apr-11 Oct-11 Apr-12 Oct-12 Apr-13 Oct-13 Apr-14 Oct-14 Apr-15
UBS (CH) Vitainvest - 12 World U UBS (CH) Vitainvest - 25 World U UBS (CH) Vitainvest - 40 World U
UBS (CH) Vitainvest - 50 World U UBS (CH) Vitainvest - 25 Swiss U UBS (CH) Vitainvest - 50 Swiss U
Performance
Fund Valor MtD YtD 1 Year *3 Years *5 Years
UBS (CH) Vitainvest - 12 World U 2'247'644 1.27% -0.08% 1.86% 2.85% 2.61%
UBS (CH) Vitainvest - 25 World U 2'247'646 2.19% -0.09% 2.25% 4.30% 3.37%
UBS (CH) Vitainvest - 40 World U 2'247'648 3.18% 0.11% 2.58% 6.02% 4.32%
UBS (CH) Vitainvest - 50 World U 2'247'650 3.50% 0.22% 2.44% 6.53% 4.67%
UBS (CH) Vitainvest - 25 Swiss U 10'852'691 2.20% 1.92% 3.98% 5.12% 4.06%
UBS (CH) Vitainvest - 50 Swiss U 10'852'698 3.03% 1.82% 4.28% 7.44% 5.47%
Data as of October 30, 2015, net of fees These figures refer to the past. Past performance is not a reliable indicator of future results.
Investment process
Section 2
8
Pillars of a professional portfolio management
Long term (strategic) Asset Allocation (SAA)
A well chosen reference strategy ensures the diversification over a broad investment universe.
Short term (tactical) Asset Allocation (TAA)
Over-/underweight the different asset classes vs reference strategy with the target to benefit from opportunities which are ranked as attractive, based on the actual economic environment.
Active Stock Selection
Careful selection of single stocks which promise an attractive return potential compared to the risk taken.
Active Risk Management
Asses risk-/return characteristics of each investment for the portfolio as a whole.
Based on the risk profile of the portfolio a risk position will only be entered, when we expect an appropriate return
Monitoring the risk with state of the art systems, which enables us to estimate effects of potential strategy changes on the portfolio.
9
Broad experience in one solution
Investment strategies with different
risk-/return characteristics
Equity Real Estate Fixed Income
Portfolio management Implementation of the strategies
Stock selection Risk monitoring
Reporting
Portfolio construction
Optimization
Investment restriction
Investment decision
10
Attractive fund-of-funds concept
• Efficient Fund-of-Funds solution, where first class equity, fixed income and real estate funds are combined, matching the corresponding investment strategy
• No hidden fees within the target funds, which offer a no load share class (predominantly the case)
• High transparency for investors, since positions can be shown down to stock level.
• To increase portfolio efficiency, derivatives will also be used for investments
• Consistent risk monitoring with state of the art system
UBS (CH) Inst. Fund – Bonds CHF Inland
(seit 1995)
UBS (CH) Inst. Fund – Small & Mid Cap
Equities Switzerland (seit 2003)
UBS (CH) Property Fund – Léman Residential
«Foncipars» (seit 1943)
Only for illustration purposes
UBS Vitainvest
Swiss
UBS Vitainvest implements the strategies mostly with funds belonging to UBS
Advantage for investors
With UBS Vitainvest an investors receives access to a professional managed investment solution with just one transaction
Possible Target Funds
(UBS Vitainvest Swiss)
11
Asset manager of the UBS Vitainvest Funds Access to the leading asset managers
Asset class Asset manager
Swiss Bonds • UBS Asset Management
Global Bonds • BlackRock Investment Management (UK) Ltd. • PIMCO • UBS Asset Management
Swiss Equity • Deutsche Asset Management Schweiz AG • IAM Independent Asset Management SA • Schroders Investment Management (Switzerland) AG • UBS Asset Management
Global Equity • Allianz Global Investors Anlagegesellschaft mbH (RCM) • Investec Asset Management Ltd. • PanAgora Asset Management • UBS Asset Management
.Data as end of September 2015
12
Important aspect – risk management Analysis of single scenarios
Source: UBS Asset Management, Global Risk System For illustrative purposes only
Technical data
Appendix A
14
UBS Vitainvest World
Legal fund name: UBS (CH) Vitainvest – 12 / 25 / 40 / 50 / 75 World
Fund domicile: Switzerland
Day of inception: 12 / 25 / 40 / 50 World U: 20. January 2006 75 World U: 05. November 2015
Currency of account: CHF
Reference strategy: UBS Customized Benchmark Vitainvest – 12 / 25 / 40 / 50 / 75 World
Accounting year ends: 31. December
Subscriptions / redemptions: Daily
Distribution: Yes
Management fee and Total Expense Ratio (TER):
Management fee TER (per 31.12.2014)
12 World U: 0.92% p.a. 1.20% p.a. 25 World U: 1.04% p.a. 1.35% p.a. 40 World U: 1.12% p.a. 1.45% p.a. 50 World U: 1.20% p.a. 1.55% p.a. 75 World U: 1.28% p.a. n.a.
EU savings tax: Not affected in booking center CH, affected in other booking centers
Swing Pricing: Yes
Swiss security No and ISIN: Swiss security No ISIN
12 World U: 2 247 644 CH0022476441 25 World U: 2 247 646 CH0022476466 40 World U: 2 247 648 CH0022476482 50 World U: 2 247 650 CH0022476508 75 World U: 29 317 460 CH0293174600
Technical data
.Data as end of August 2015
15
UBS Vitainvest Swiss Technical data
Legal fund name: UBS (CH) Vitainvest – 25 / 50 / 75 Swiss
Fund domicile: Switzerland
Day of inception: 25 / 50 Swiss U: 25. May 2010 75 Swiss U: 05. November 2015
Currency of account: CHF (exchange rate risk mostly hedged)
Reference strategy: UBS Customized Benchmark Vitainvest – 25 / 50 / 75 Swiss
Accounting year ends: 31. December
Subscriptions / redemptions: Daily
Distribution: Yes
Management fee and Total Expense Ratio (TER):
Management fee TER (per 31.12.2014)
25 Swiss U: 1.00% p.a. 1.19% p.a.
50 Swiss U: 1.12% p.a. 1.34% p.a. 75 Swiss U: 1.20% p.a. n.a.
EU saving tax: Not affected in booking center CH, affected in other booking centers
Swing Pricing: Yes
Swiss security No and ISIN: Swiss Security No ISIN
25 Swiss U: 10 852 691 CH0108526911 50 Swiss U: 10 852 698 CH0108526986 75 Swiss U: 29 317 503 CH0293175037
.Data as end of August 2015
16
Disclaimer
For marketing and information purposes by UBS.
For qualified investors only. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. UBS funds under Swiss law. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management. This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.
Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS AG, P.O. Box, CH-4002 Basel or from UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel.
© UBS 2015. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
top related